Preview Mode Links will not work in preview mode

This Week in Cardiology

Mar 10, 2023

ACC Recap Part 1: Sports, bempedoic acid NASCARs, tricuspid regurgitation, and more on revascularization of stable CAD. are the topics discussed by John Mandrola, MD, in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Sports Cardiology

Even Vigorous Exercise Appears Safe for Patients With Hypertrophic Cardiomyopathy: LIVE-HCM

- Lifelong endurance exercise and its relation with coronary atherosclerosis

- Increased average longevity among the "Tour de France" cyclists

II. Clear Outcomes

Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients: CLEAR Outcomes

- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

- Bodgan Enache Tweet


Transcatheter Tricuspid Valve Repair Effective, Safe for Regurgitation: TRILUMINATE

- Transcatheter Repair for Patients with Tricuspid Regurgitation

- New Treatment Could Help Fix the Heart’s ‘Forgotten Valve.’

- Rasha Al-Lamee Tweet


Viability-Guided PCI Doubted in Stable Severe CAD: REVIVED-BCIS2

- Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction


CLEAR Positives and Cautions With Bempedoic Acid for Statin Intolerance

The TRILUMINATE Transcatheter Tricuspid Repair Trial: Positive but No Benefit?

Three Surprising Studies on Exercise Restriction and an Exercise Sweet Spot

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact